Versican: A Dynamic Regulator of the Extracellular Matrix.

Abstract

Versican is a large chondroitin sulfate/dermatan sulfate proteoglycan belonging to the aggrecan/lectican family. In adults, this proteoglycan serves as a structural macromolecule of the extracellular matrix in the brain and large blood vessels. In contrast, versican is transiently expressed at high levels during development and under pathological conditions when the extracellular matrix dramatically changes, including in the inflammation and repair process. There are many reports showing the upregulation of versican in cancer, which correlates with cancer aggressiveness. Versican has four classical splice variants, and all the variants contain G1 and G3 domains at N- and C-termini, respectively. There are two glycosaminoglycan attachment domains CSα and CSβ. The largest V0 variant contains both CSα and CSβ, V1 contains CSβ, V2 contains CSα, and the shortest G3 variant has neither of them. Versican degradation is initiated by cleavage at a site in the CSβ domain by ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) proteinases. The N-terminal fragment containing the G1 domain has been reported to exert various biological functions, although its mechanisms of action have not yet been elucidated. In this review, we describe the role of versican in inflammation and cancer and also address the biological function of versikine.

• Authors: Shamima Islam, Hideto Watanabe
• Journal: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society (J Histochem Cytochem) Vol. 68 Issue 11 Pg. 763-775 (11 2020) ISSN: 1551-5044 [Electronic] United States
• PMID: 33131383 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Versicans

Topics

• Animals
• Extracellular Matrix (metabolism)
• Humans
• Inflammation (metabolism)
• Neoplasms (metabolism)
• Versicans (metabolism)